Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research

International Journal of Developmental Neuroscience

Volumn 51, Issue , 2016, Pages 50-72

  Glover, Matthew E ^a   Clinton, Sarah M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Anxiety; Behavior; Depression; Epigenetics; Hippocampus; Neurogenesis; Rodent models; Serotonin; SSRI

Indexed keywords

SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SEROTONIN;

ANXIETY; AUTISM; BRAIN DEVELOPMENT; CHILD BEHAVIOR; COGNITION; DEPRESSION; EXPLORATORY BEHAVIOR; FETUS MALFORMATION; FORCED SWIM TEST; HIPPOCAMPUS; HUMAN; NERVE CELL DIFFERENTIATION; NERVE PROJECTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERINATAL DRUG EXPOSURE; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RAPHE NUCLEUS; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; SOCIAL BEHAVIOR; WITHDRAWAL SYNDROME; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; LIMBIC SYSTEM; METABOLISM; MOOD DISORDERS; PHYSIOLOGY; PRECLINICAL STUDY; PREGNANCY; PRENATAL EXPOSURE; SIGNAL TRANSDUCTION;

ANIMALS; DRUG EVALUATION, PRECLINICAL; FEMALE; HIPPOCAMPUS; HUMANS; LIMBIC SYSTEM; MOOD DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 84969520086     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2016.04.008     Document Type: Review

References (351)

1. Abrams J.K., et al. Anatomic and functional topography of the dorsal raphe nucleus. Ann. N. Y. Acad. Sci. 2004, 1018:46-57.
2. Ahlemeyer B., et al. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5HT(1A)-receptor agonist: bay ×3702. Brain Res. 2000, 858(1):121-128.
3. Aitken A.R., Tork I. Early development of serotonin-containing neurons and pathways as seen in wholemount preparations of the fetal rat brain. J. Comp. Neurol. 1988, 274(1):32-47.
4. Alenina N., Klempin F. The role of serotonin in adult hippocampal neurogenesis. Behav. Brain Res. 2015, 277:49-57.
5. Alenina N., Bashammakh S., Bader M. Specification and differentiation of serotonergic neurons. Stem Cell Rev. 2006, 2(1):5-10.
6. Altamura C., et al. Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb. Cortex 2007, 17(6):1394-1401.
7. Alwan S., Friedman J.M. Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs 2009, 23(6):493-509.
8. Alwan S., et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N. Engl. J. Med. 2007, 356(26):2684-2692.
9. American Psychiatric Association DSM-5 Task Force., Diagnostic and Statistical Manual of Mental Disorders: DSM-5 2016, American Psychiatric Publishing., and American Psychiatric Association, 1 online resource. 5th edition.
10. Andrade S.E., et al. Use of antidepressant medications during pregnancy: a multisite study. Am. J. Obstet. Gynecol. 2008, 198(2):e1-e5.
11. Ansorge M.S., et al. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306(5697):879-881.
12. Ansorge M.S., Morelli E., Gingrich J.A. Inhibition of serotonin but not norepinephrine transport during development produces delayed: persistent perturbations of emotional behaviors in mice. J. Neurosci. 2008, 28(1):199-207.
13. Azmitia E.C., et al. S100 beta and serotonin: a possible astrocytic-neuronal link to neuropathology of Alzheimer's disease. Prog. Brain Res. 1992, 94:459-473.
14. Azmitia E.C., et al. 5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Brain Res. 1995, 677(2):181-192.
15. Azmitia E.C., et al. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 1996, 14(1):35-46.
16. Azmitia E.C. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 1999, 21(Suppl. 2):33S-45S.
17. Bairy K.L., et al. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2007, 79(1):1-11.
18. Baker K.G., et al. Distribution: morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience 1991, 42(3):757-775.
19. Bakker M.K., et al. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade: a population-based cohort study from the Netherlands. Br. J. Clin. Pharmacol. 2008, 65(4):600-606.
20. Bakker M.K., et al. First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. Birth Defects Res. A Clin. Mol. Teratol. 2010, 88(2):94-100.
21. Ballion B., et al. Ontogeny of descending serotonergic innervation and evidence for intraspinal 5-HT neurons in the mouse spinal cord. Brain Res. Dev. Brain Res. 2002, 137(1):81-88.
22. Bannerman D.M., et al. Double dissociation of function within the hippocampus: spatial memory and hyponeophagia. Behav. Neurosci. 2002, 116(5):884-901.
23. Bannerman D.M., et al. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav. Brain Res. 2003, 139(1-2):197-213.
24. Bannerman D.M., et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci. Biobehav. Rev. 2004, 28(3):273-283.
25. Bar-Oz B., et al. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin. Ther. 2007, 29(5):918-926.
26. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38(8):1083-1152.
27. Beck S.G., et al. Median and dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol. 2004, 91(2):994-1005.
28. Behzadi G., et al. Afferents to the median raphe nucleus of the rat: retrograde cholera toxin and wheat germ conjugated horseradish peroxidase tracing, and selective D-[3H]aspartate labelling of possible excitatory amino acid inputs. Neuroscience 1990, 37(1):77-100.
29. Beiderbeck D.I., Neumann I.D., Veenema A.H. Differences in intermale aggression are accompanied by opposite vasopressin release patterns within the septum in rats bred for low and high anxiety. Eur. J. Neurosci. 2007, 26(12):3597-3605.
30. Belzung C. Hippocampal mossy fibres: implication in novelty reactions or in anxiety behaviours?. Behav. Brain Res. 1992, 51(2):149-155.
31. Bennett H.A., et al. Prevalence of depression during pregnancy: systematic review. Obstet. Gynecol. 2004, 103(4):698-709.
32. Benton C.S., et al. Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology (Berl.) 2012, 221(2):297-315.
33. Berard A., et al. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res. B Dev. Reprod. Toxicol. 2007, 80(1):18-27.
34. Bernard R., Veh R.W. Individual neurons in the rat lateral habenular complex project mostly to the dopaminergic ventral tegmental area or to the serotonergic raphe nuclei. J. Comp. Neurol. 2012, 520(11):2545-2558.
35. Bertoglio L.J., Joca S.R., Guimaraes F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav. Brain Res. 2006, 175(1):183-188.
36. Berumen L.C., et al. Serotonin receptors in hippocampus. Sci. World J. 2012, 2012:823493.
37. Bhagya V., et al. The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits: biochemical changes, and hippocampal synaptic plasticity in an animal model of depression. J. Neurosci. Res. 2015, 93(1):104-120.
38. Binder E., et al. Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenet. Genomics 2011, 21(12):779-789.
39. Blakely R.D., et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature 1991, 354(6348):66-70.
40. Blanchard M.M., Mendelsohn D., Stamp J.A. The HR/LR model: further evidence as an animal model of sensation seeking. Neurosci. Biobehav. Rev. 2009, 33(7):1145-1154.
41. Blier P. Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles. J. Psychiatry Neurosci. 2001, 26(Suppl):S1-S2.
42. Blue M.E., Erzurumlu R.S., Jhaveri S. A comparison of pattern formation by thalamocortical and serotonergic afferents in the rat barrel field cortex. Cereb. Cortex 1991, 1(5):380-389.
43. Bonnin A., et al. A transient placental source of serotonin for the fetal forebrain. Nature 2011, 472(7343):347-350.
44. Borri C., et al. Axis I psychopathology and functional impairment at the third month of pregnancy: results from the perinatal depression-research and screening unit (PND-ReScU) study. J. Clin. Psychiatry 2008, 69(10):1617-1624.
45. Bos K., et al. Psychiatric outcomes in young children with a history of institutionalization. Harv. Rev. Psychiatry 2011, 19(1):15-24.
46. Bosch O.J. Maternal nurturing is dependent on her innate anxiety: the behavioral roles of brain oxytocin and vasopressin. Horm. Behav. 2011, 59(2):202-212.
47. Boukhris T., et al. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2015, 1-8.
48. Boulle F., et al. Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring. Horm. Behav. 2016.
49. Bourke C.H., et al. Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats. Neurotoxicol. Teratol. 2013, 39:100-109.
50. Bowker R.M., et al. Mapping monoaminergic and peptidergic pathways. Prog. Clin. Biol. Res. 1982, 79:115-130.
51. Brandlistuen R.E., et al. Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings. Int. J. Epidemiol. 2015, 44(4):1397-1407.
52. Bunney W.E., Davis J.M. Norepinephrine in depressive reactions. A review. Arch. Gen. Psychiatry 1965, 13(6):483-494.
53. Calizo L.H., et al. Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence. Neuropharmacology 2011, 61(3):524-543.
54. Carreno F.R., et al. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine. Mol. Psychiatry 2015.
55. Carson M.J., et al. The 5HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes. Glia 1996, 17(4):317-326.
56. Cases O., et al. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 1996, 16(2):297-307.
57. Cases O., et al. Plasma membrane transporters of serotonin: dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. J. Neurosci. 1998, 18(17):6914-6927.
58. Cassel S., et al. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol. Pharmacol. 2006, 70(2):487-492.
59. Clements C.C., et al. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol. Psychiatry 2015, 20(6):727-734.
60. Clinton S.M., Watson S.J., Akil H. High novelty-seeking rats are resilient to negative physiological effects of the early life stress. Stress 2014, 17(1):97-107.
61. Cole J.A., et al. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol. Drug Saf. 2007, 16(10):1075-1085.
62. Coleman F.H., et al. Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil). Am. J. Obstet. Gynecol. 1999, 181(5 Pt. 1):1166-1171.
63. Colgin L.L., Moser E.I. Gamma oscillations in the hippocampus. Physiology (Bethesda) 2010, 25(5):319-329.
64. Cooper W.O., et al. Increasing use of antidepressants in pregnancy. Am. J. Obstet. Gynecol. 2007, 196(6):544e1-544e5.
65. Coppen A.J. Depressed states and indolealkylamines. Adv. Pharmacol. 1968, 6(Pt. B):283-291.
66. Costa L., et al. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. Hippocampus 2012, 22(4):790-801.
67. Covington H.E., et al. Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 2009, 29(37):11451-11460.
68. Craven S.E., et al. Gata2 specifies serotonergic neurons downstream of sonic hedgehog. Development 2004, 131(5):1165-1173.
69. Crawford L.K., Craige C.P., Beck S.G. Increased intrinsic excitability of lateral wing serotonin neurons of the dorsal raphe: a mechanism for selective activation in stress circuits. J. Neurophysiol. 2010, 103(5):2652-2663.
70. Croen L.A., et al. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch. Gen. Psychiatry 2011, 68(11):1104-1112.
71. Cropper E.C., Eisenman J.S., Azmitia E.C. An immunocytochemical study of the serotonergic innervation of the thalamus of the rat. J. Comp. Neurol. 1984, 224(1):38-50.
72. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29(4-5):547-569.
73. Darling R.D., et al. Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats. J. Neurosci. 2011, 31(46):16709-16715.
74. David D.J., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62(4):479-493.
75. Dayan J., et al. Role of anxiety and depression in the onset of spontaneous preterm labor. Am. J. Epidemiol. 2002, 155(4):293-301.
76. Diav-Citrin O., et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br. J. Clin. Pharmacol. 2008, 66(5):695-705.
77. Djavadian R.L. Serotonin and neurogenesis in the hippocampal dentate gyrus of adult mammals. Acta Neurobiol. Exp. (Wars) 2004, 64(2):189-200.
78. Drugan R.C., et al. Prior cold water swim stress alters immobility in the forced swim test and associated activation of serotonergic neurons in the rat dorsal raphe nucleus. Neuroscience 2013, 253:221-234.
79. Eichenbaum H., Otto T., Cohen N.J. The hippocampus-what does it do?. Behav. Neural Biol. 1992, 57(1):2-36.
80. Einarson A., et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am. J. Psychiatry 2008, 165(6):749-752.
81. El Marroun H., et al. Maternal use of selective serotonin reuptake inhibitors: fetal growth, and risk of adverse birth outcomes. Arch. Gen. Psychiatry 2012, 69(7):706-714.
82. Ellfork M., Malm H. Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). Reprod. Toxicol. 2010, 30(2):249-260.
83. Eluvathingal T.J., et al. Abnormal brain connectivity in children after early severe socioemotional deprivation: a diffusion tensor imaging study. Pediatrics 2006, 117(6):2093-2100.
84. Ely D.L., Greene E.G., Henry J.P. Effects of hippocampal lesion on cardiovascular: adrenocortical and behavioral response patterns in mice. Physiol. Behav. 1977, 18(6):1075-1083.
85. Emslie G., Judge R. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatr. Scand. Suppl. 2000, 403:26-34.
86. Engin E., Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behav. Pharmacol. 2007, 18(5-6):365-374.
87. Ergorul C., Eichenbaum H. The hippocampus and memory for what, 'where, and when'. Learn. Mem. 2004, 11(4):397-405.
88. Eriksen H.L., et al. No association between prenatal exposure to psychotropics and intelligence at age five. Acta Obstet. Gynecol. Scand. 2015, 94(5):501-507.
89. Feenstra M.G., et al. Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine. Pharmacol. Biochem. Behav. 1996, 55(4):647-652.
90. Felix-Ortiz A.C., Tye K.M. Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior. J. Neurosci. 2014, 34(2):586-595.
91. Feng X., et al. Emotion regulation in preschoolers: the roles of behavioral inhibition, maternal affective behavior, and maternal depression. J. Child Psychol. Psychiatry 2008, 49(2):132-141.
92. Figueroa R. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J. Dev. Behav. Pediatr. 2010, 31(8):641-648.
93. Fink K.B., Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol. Rev. 2007, 59(4):360-417.
94. Flagel S.B., et al. Antecedents and consequences of drug abuse in rats selectively bred for high and low response to novelty. Neuropharmacology 2014, 76(Pt. B):425-436.
95. Foote S.L., Morrison J.H. Development of the noradrenergic, serotonergic, and dopaminergic innervation of neocortex. Curr. Top. Dev. Biol. 1987, 21:391-423.
96. Fortin N.J., Agster K.L., Eichenbaum H.B. Critical role of the hippocampus in memory for sequences of events. Nat. Neurosci. 2002, 5(5):458-462.
97. Frankova S., Mikulecka A. Ontogeny of social behavior of pups of laboratory rats genetically selected for activity level. Act. Nerv. Super. (Praha) 1990, 32(3):167-173.
98. Fu W., et al. Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain. J. Comp. Neurol. 2010, 518(17):3464-3494.
99. Galter D., Unsicker K. Brain-derived neurotrophic factor and trkB are essential for cAMP-mediated induction of the serotonergic neuronal phenotype. J. Neurosci. Res. 2000, 61(3):295-301.
100. Garcia-Fuster M.J., et al. The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior. Eur. Neuropsychopharmacol. 2011.
101. Gardner K.L., et al. Early life experience alters behavior during social defeat: focus on serotonergic systems. Neuroscience 2005, 136(1):181-191.
102. Gaspar P., Lillesaar C. Probing the diversity of serotonin neurons. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2012, 367(1601):2382-2394.
103. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4(12):1002-1012.
104. Gentile S., Galbally M. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. J. Affect. Disord. 2011, 128(1-2):1-9.
105. Gentile S. Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?. J. Affect. Disord. 2015, 182:132-137.
106. Gervasoni D., et al. Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurons. J. Neurosci. 2000, 20(11):4217-4225.
107. Ghosh M., Pearse D.D. The role of the serotonergic system in locomotor recovery after spinal cord injury. Front Neural Circuits 2014, 8:151.
108. Gidaya N.B., et al. In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J. Autism Dev. Disord. 2014, 44(10):2558-2567.
109. Glover M.E., et al. Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats. Neuroscience 2015, 284:775-797.
110. Glover M.E., et al. Early-Life Exposure to the SSRI Paroxetine Disrupts DNA Methylation in the Early Postnatal Hippocampus 2015, Society for Neuroscience Abstracts, Chicago, IL.
111. Gocho Y., et al. Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus. J. Physiol. Sci. 2013, 63(2):147-154.
112. Gray J.A., McNaughton N. The neuropsychology of anxiety: reprise. Nebr. Symp. Motiv. 1996, 43:61-134.
113. Gray J.A. The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System 1982, Oxford University Press, Oxford, UK.
114. Gutknecht L., et al. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur. Neuropsychopharmacol. 2009, 19(4):266-282.
115. Hanley G.E., Brain U., Oberlander T.F. Infant developmental outcomes following prenatal exposure to antidepressants: and maternal depressed mood and positive affect. Early Hum. Dev. 2013, 89(8):519-524.
116. Hanley G.E., Brain U., Oberlander T.F. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr. Res. 2015, 78(2):174-180.
117. Hannon J., Hoyer D. Molecular biology of 5-HT receptors. Behav. Brain Res. 2008, 195(1):198-213.
118. Hansen H.H., Sanchez C., Meier E. Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression?. J. Pharmacol. Exp. Ther. 1997, 283(3):1333-1341.
119. Haring J.H., et al. Hippocampal serotonin levels influence the expression of S100 beta detected by immunocytochemistry. Brain Res. 1993, 631(1):119-123.
120. Harrington R.A., et al. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy. Autism. Res. 2013, 6(3):149-168.
121. Harrington R.A., et al. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 2014, 133(5):e1241-8.
122. Harris S.S., et al. Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat. Brain Res. 2012, 1429:52-60.
123. Hartley P.S., et al. Food-entrained rhythmic expression of PER2 and BMAL1 in murine megakaryocytes does not correlate with circadian rhythms in megakaryopoiesis. J. Thromb. Haemost. 2008, 6(7):1144-1152.
124. Hayes R.M., et al. Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies. Am. J. Obstet. Gynecol. 2012, 207(1):49e1-49e9.
125. Heils A., et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66(6):2621-2624.
126. Hendricks T., et al. The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J. Neurosci. 1999, 19(23):10348-10356.
127. Hermansen T.K., et al. Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression. Psychopharmacology (Berl.) 2016, 233(8):1523-1535.
128. Hilakivi L.A., Hilakivi I. Increased adult behavioral 'despair' in rats neonatally exposed to desipramine or zimeldine: an animal model of depression?. Pharmacol. Biochem. Behav. 1987, 28(3):367-369.
129. Hill A.S., Sahay A., Hen R. Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors. Neuropsychopharmacology 2015, 40(10):2368-2378.
130. Hirschfeld R.M. History and evolution of the monoamine hypothesis of depression. J. Clin. Psychiatry 2000, 61(Suppl. 6):4-6.
131. Hitti F.L., Siegelbaum S.A. The hippocampal CA2 region is essential for social memory. Nature 2014, 508(7494):88-92.
132. Hochstrasser T., et al. Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices. Neuroscience 2011, 184:128-138.
133. Hole K. Behavior and brain growth in rats treated with p-chlorophenylalanine in the first weeks of life. Dev. Psychobiol. 1972, 5(2):157-173.
134. Holick K.A., et al. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 2008, 33(2):406-417.
135. Homberg J.R., Schubert D., Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol. Sci. 2010, 31(2):60-65.
136. Hornung J.P., Celio M.R. The selective innervation by serotoninergic axons of calbindin-containing interneurons in the neocortex and hippocampus of the marmoset. J. Comp. Neurol. 1992, 320(4):457-467.
137. Hornung J.P., Fritschy J.M., Tork I. Distribution of two morphologically distinct subsets of serotoninergic axons in the cerebral cortex of the marmoset. J. Comp. Neurol. 1990, 297(2):165-181.
138. Hynes M., et al. The seven-transmembrane receptor smoothened cell-autonomously induces multiple ventral cell types. Nat. Neurosci. 2000, 3(1):41-46.
139. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992, 72(1):165-229.
140. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 1991, 12(2):118-134.
141. Jama A., et al. Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test. Psychopharmacology (Berl.) 2008.
142. Jay T.M., Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J. Comp. Neurol. 1991, 313(4):574-586.
143. Jeewajee A., et al. Environmental novelty is signaled by reduction of the hippocampal theta frequency. Hippocampus 2008, 18(4):340-348.
144. Jensen P., et al. Redefining the serotonergic system by genetic lineage. Nat. Neurosci. 2008, 11(4):417-419.
145. Jimenez-Solem E., et al. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012, 2(3).
146. Johnston A., McBain C.J., Fisahn A. 5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation. J. Physiol. 2014, 592(Pt. 19):4187-4199.
147. Johnston A., McBain C.J., Fisahn A. 5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation. J. Physiol. 2014, 592(19):4187-4199.
148. Kabbaj M., et al. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J. Neurosci. 2000, 20(18):6983-6988.
149. Kabbaj M. Neurobiological bases of individual differences in emotional and stress responsiveness: high responders-low responders model. Arch. Neurol. 2004, 61(7):1009-1012.
150. Kagan J., Snidman N. Early childhood predictors of adult anxiety disorders. Biol. Psychiatry 1999, 46(11):1536-1541.
151. Kalen P., Karlson M., Wiklund L. Possible excitatory amino acid afferents to nucleus raphe dorsalis of the rat investigated with retrograde wheat germ agglutinin and D-[3H]aspartate tracing. Brain Res. 1985, 360(1-2):285-297.
152. Kallen B., Otterblad Olausson P. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod. Toxicol. 2006, 21(3):221-222.
153. Karpova N.N., et al. Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur. Neuropsychopharmacol. 2009, 19(2):97-108.
154. Kelly K.J., et al. Swim stress activates serotonergic and nonserotonergic neurons in specific subdivisions of the rat dorsal raphe nucleus in a temperature-dependent manner. Neuroscience 2011, 197:251-268.
155. Kepser L.J., Homberg J.R. The neurodevelopmental effects of serotonin: a behavioural perspective. Behav. Brain Res. 2015, 277:3-13.
156. Kinney G.G., Vogel G.W., Feng P. Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Res. 1997, 756(1-2):68-75.
157. Kinsey A.M., et al. Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. Brain Res. Mol. Brain Res. 2001, 88(1-2):194-198.
158. Kiyasova V., et al. A subpopulation of serotonergic neurons that do not express the 5-HT1A autoreceptor. ACS Chem. Neurosci. 2013, 4(1):89-95.
159. Klinger G., Merlob P. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Isr. J. Psychiatry Relat. Sci. 2008, 45(2):107-113.
160. Klinger G., et al. Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. J. Perinatol. 2011, 31(9):615-620.
161. Knaepen L., et al. Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague-Dawley rat offspring. PLoS One 2013, 8(2):e57608.
162. Kocsis B., et al. Serotonergic neuron diversity: identification of raphe neurons with discharges time-locked to the hippocampal theta rhythm. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(4):1059-1064.
163. Kolb B., Nonneman A.J. Frontolimbic lesions and social behavior in the rat. Physiol. Behav. 1974, 13(5):637-643.
164. Kornum J.B., et al. Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin. Epidemiol. 2010, 2:29-36.
165. Krettek J.E., Price J.L. Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat. J. Comp. Neurol. 1977, 172(4):723-752.
166. Kusek M., et al. 5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin. Front. Cell. Neurosci. 2015, 9:324.
167. Landgraf R., Wigger A. High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav.Genet. 2002, 32(5):301-314.
168. Lapin I.P., Oxenkrug G.F. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1969, 1(7586):132-136.
169. Lauder J.M., Krebs H. Serotonin as a differentiation signal in early neurogenesis. Dev. Neurosci. 1978, 1(1):15-30.
170. Lebrand C., et al. Transient developmental expression of monoamine transporters in the rodent forebrain. J. Comp. Neurol. 1998, 401(4):506-524.
171. Lee L.J., Lee L.J. Neonatal fluoxetine exposure alters motor performances of adolescent rats. Dev. Neurobiol. 2012, 72(8):1122-1132.
172. Lee H.S., et al. Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res. 2003, 963(1-2):57-71.
173. Lee L.J. Neonatal fluoxetine exposure affects the neuronal structure in the somatosensory cortex and somatosensory-related behaviors in adolescent rats. Neurotox. Res. 2009, 15(3):212-223.
174. Leonard B.E. Evidence for a biochemical lesion in depression. J. Clin. Psychiatry 2000, 61(Suppl. 6):12-17.
175. Lesch K.P., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274(5292):1527-1531.
176. Leslie M.J., Bennett-Clarke C.A., Rhoades R.W. Serotonin 1B receptors form a transient vibrissa-related pattern in the primary somatosensory cortex of the developing rat. Brain Res. Dev. Brain Res. 1992, 69(1):143-148.
177. Lever C., Burton S., O'Keefe J. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev. Neurosci. 2006, 17(1-2):111-133.
178. Levinson-Castiel R., et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch. Pediatr. Adolesc. Med. 2006, 160(2):173-176.
179. Liao C.C., Lee L.J. Neonatal fluoxetine exposure affects the action potential properties and dendritic development in cortical subplate neurons of rats. Toxicol. Lett. 2011, 207(3):314-321.
180. Lidov H.G., Molliver M.E. An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res. Bull. 1982, 8(4):389-430.
181. Limon-Morales O., et al. Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine. Physiol. Behav. 2014, 124:37-44.
182. Lisboa S.F., et al. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 2007, 80(1):49-56.
183. Liu R., Jolas T., Aghajanian G. Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res. 2000, 873(1):34-45.
184. Liu H., et al. Acute tryptophan depletion reduces nitric oxide synthase in the rat hippocampus. Neurochem. Res. 2013, 38(12):2595-2603.
185. Louik C., et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N. Engl. J. Med. 2007, 356(26):2675-2683.
186. Lowry C.A., et al. Topographic organization and chemoarchitecture of the dorsal raphe nucleus and the median raphe. Serotonin and Sleep: Molecular, Functional and Clinical Aspects 2008, 25-67. Birkhäuser Verlag, Switzerland. J.M. Monti (Ed.).
187. Luedi P.P., Hartemink A.J., Jirtle R.L. Genome-wide prediction of imprinted murine genes. Genome Res. 2005, 15(6):875-884.
188. Lund N., Pedersen L.H., Henriksen T.B. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch. Pediatr. Adolesc. Med. 2009, 163(10):949-954.
189. Maaswinkel H., et al. Roles of the basolateral amygdala and hippocampus in social recognition in rats. Physiol. Behav. 1996, 60(1):55-63.
190. Maaswinkel H., Gispen W.H., Spruijt B.M. Executive function of the hippocampus in social behavior in the rat. Behav. Neurosci. 1997, 111(4):777-784.
191. MacLean K. The impact of institutionalization on child development. Dev. Psychopathol. 2003, 15(4):853-884.
192. Maciag D., et al. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006, 31(1):47-57.
193. Maciag D., Coppinger D., Paul I.A. Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development. Brain Res. 2006, 1125(1):171-175.
194. Maciag D., et al. Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment. Eur. J. Pharmacol. 2006, 532(3):265-269.
195. Mahar I., et al. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci. Biobehav. Rev. 2014, 38:173-192.
196. Malm H., Gissler M B.A., Gyllenberg D., Hinkka-Yli-Salomäki S., McKeague I.W., Weissman M., Wickramaratne P., Artama M., Gingrich J.A., Sourander A. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J. Am. Acad. Child Adolesc. Psychiatry 2016.
197. Mamounas L.A., et al. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 1995, 15(12):7929-7939.
198. Man K.K., et al. Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies. Neurosci. Biobehav. Rev. 2015, 49:82-89.
199. Manhaes de Castro R., et al. Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor. Braz. J. Med. Biol. Res. 2001, 34(1):121-124.
200. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999, 21(Suppl. 2):99S-105S.
201. Marcus S.M. Depression during pregnancy: rates, risks and consequences-motherisk update 2008. Can. J. Clin. Pharmacol. 2009, 16(1):e15-e22.
202. Marquez C., Nadal R., Armario A. Influence of reactivity to novelty and anxiety on hypothalamic-pituitary-adrenal and prolactin responses to two different novel environments in adult male rats. Behav. Brain Res. 2006, 168(1):13-22.
203. Martin, J.A.,Preterm births-United States, 2007. MMWR Surveill Summ, 2011. 60 Suppl: p. 78-9.
204. Mathews T.A., et al. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J. Neurosci. Methods 2004, 140(1-2):169-181.
205. Mazer C., et al. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 1997, 760(1-2):68-73.
206. McAllister B.B., Kiryanova V., Dyck R.H. Behavioural outcomes of perinatal maternal fluoxetine treatment. Neuroscience 2012, 226:356-366.
207. McEwen B.S., Gould E.A., Sakai R.R. The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br. J. Psychiatry Suppl. 2016, 1992(15):18-23.
208. McEwen B.S. Early life influences on life-long patterns of behavior and health. Ment. Retard. Dev. Disabil. Res. Rev. 2003, 9(3):149-154.
209. McNaughton N., Gray J.A. Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J. Affect. Disord. 2000, 61(3):161-166.
210. McNaughton N. Cognitive dysfunction resulting from hippocampal hyperactivity-a possible cause of anxiety disorder?. Pharmacol. Biochem. Behav. 1997, 56(4):603-611.
211. Melas P.A., et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int. J. Neuropsychopharmacol. 2012, 15(5):669-679.
212. Meloni E.G., et al. Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior. Biol. Psychiatry 2008, 63(9):832-839.
213. Mendes-da-Silva C., et al. Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats. Arq. Neuropsiquiatr. 2002, 60(4):928-931.
214. Menke A., Klengel T., Binder E.B. Epigenetics: depression and antidepressant treatment. Curr. Pharm. Des. 2012, 18(36):5879-5889.
215. Michal E.K. Effects of limbic lesions on behavior sequences and courtship behavior of male rats (Rattus norvegicus). Behaviour 1973, 44(3):264-285.
216. Migliarini S., et al. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol. Psychiatry 2013, 18(10):1106-1118.
217. Ming G.L., Song H. Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 2005, 28:223-250.
218. Mirmiran M., et al. Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res. 1981, 204(1):129-146.
219. Misri S., et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am. J. Psychiatry 2006, 163(6):1026-1032.
220. Mlinar B., Falsini C., Corradetti R. Pharmacological characterization of 5-HT(1B) receptor-mediated inhibition of local excitatory synaptic transmission in the CA1 region of rat hippocampus. Br. J. Pharmacol. 2003, 138(1):71-80.
221. Moffitt T.E., et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch. Gen. Psychiatry 2007, 64(6):651-660.
222. Moiseiwitsch J.R., Lauder J.M. Serotonin regulates mouse cranial neural crest migration. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(16):7182-7186.
223. Monti J.M. Serotonin and Sleep Molecular, Functional and Clinical Aspects 2008, Birkhèauser, Basel; Boston.
224. Monti J.M. The structure of the dorsal raphe nucleus and its relevance to the regulation of sleep and wakefulness. Sleep Med. Rev. 2010, 14(5):307-317.
225. Moser M.B., Moser E.I. Functional differentiation in the hippocampus. Hippocampus 1998, 8(6):608-619.
226. Mower G.D. Comparison of serotonin 5-HT1 receptors and innervation in the visual cortex of normal and dark-reared cats. J. Comp. Neurol. 1991, 312(2):223-230.
227. Muller C.L., Anacker A.M., Veenstra-VanderWeele J. The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 2015.
228. Muzerelle A., et al. Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5-B9) to the forebrain and brainstem. Brain Struct. Funct. 2016, 221(1):535-561.
229. Nishi M., Azmitia E.C. 5-HT1A receptor expression is modulated by corticosteroid receptor agonists in primary rat hippocampal culture. Brain Res. 1996, 722(1-2):190-194.
230. Nishi M., Kawata M., Azmitia E.C. Trophic interactions between brain-derived neurotrophic factor and s100beta on cultured serotonergic neurons. Brain Res. 2000, 868(1):113-188.
231. Non A.L., et al. Genome-wide DNA methylation in neonates exposed to maternal depression: anxiety, or SSRI medication during pregnancy. Epigenetics 2014, 9(7):964-972.
232. Nulman I., et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N. Engl. J. Med. 1997, 336(4):258-262.
233. Nulman I., et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am. J. Psychiatry 2002, 159(11):1889-1895.
234. Nulman I., et al. Neurodevelopment of children following prenatal exposure to venlafaxine: selective serotonin reuptake inhibitors, or untreated maternal depression. Am. J. Psychiatry 2012, 169(11):1165-1174.
235. O'Leary O.F., Cryan J.F. A ventral view on antidepressant action: roles for adult hippocampal neurogenesis along the dorsoventral axis. Trends Pharmacol. Sci. 2014, 35(12):675-687.
236. Oberlander T.F., et al. Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr. Res. 2002, 51(4):443-453.
237. Oberlander T.F., et al. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005, 115(2):411-425.
238. Oberlander T.F., et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch. Gen. Psychiatry 2006, 63(8):898-906.
239. Oberlander T.F., et al. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol. Psychiatry 2008, 13(1):65-73.
240. Oberlander T.F., et al. Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum. Dev. 2008, 84(10):689-697.
241. Oberlander T.F., Gingrich J.A., Ansorge M.S. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin. Pharmacol. Ther. 2009, 86(6):672-677.
242. Oberlander T.F., et al. Prenatal effects of selective serotonin reuptake inhibitor antidepressants: serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch. Pediatr. Adolesc. Med. 2010, 164(5):444-451.
243. Oberlander T.F. Fetal serotonin signaling: setting pathways for early childhood development and behavior. J. Adolesc. Health 2012, 51(Suppl. 2):S9-S16.
244. Olivier J.D., et al. The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011, 35(6):1400-1408.
245. Olivier J.D., et al. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl.) 2011, 217(3):419-432.
246. Parent A., Descarries L., Beaudet A. Organization of ascending serotonin systems in the adult rat brain: a radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine. Neuroscience 1981, 6(2):115-138.
247. Passani M.B., et al. Effects of DAU 6215: a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Br. J. Pharmacol. 1994, 112(2):695-703.
248. Patkar A.A., Bilal L., Masand P.S. Pharmacotherapy of depression in pregnancy. Ann. Clin. Psychiatry 2004, 16(2):87-100.
249. Pattyn A., et al. Ascl1/Mash1 is required for the development of central serotonergic neurons. Nat. Neurosci. 2004, 7(6):589-595.
250. Pawluski J.L., et al. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin: infant cortisol levels, and emerging HPA function. Psychoneuroendocrinology 2012, 37(7):1019-1028.
251. Paxinos G. The Rat Nervous System 1985, Academic Press, Sydney; Orlando.
252. Pechtel P., Pizzagalli D.A. Effects of early life stress on cognitive and affective function: an integrated review of human literature. Psychopharmacology (Berl.) 2011, 214(1):55-70.
253. Pedersen L.H., et al. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009, 339:pb3569.
254. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl.) 2005, 177(3):245-255.
255. Petrovich G.D., Canteras N.S., Swanson L.W. Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems. Brain Res. Brain Res. Rev. 2001, 38(1-2):247-289.
256. Piazza P.V., et al. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245(4925):1511-1513.
257. Piazza P.V., et al. Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc. Nat. Acad. Sci. U. S. A. 1993, 90(24):11738-11742.
258. Pitkanen A., et al. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann. N. Y. Acad. Sci. 2000, 911:369-391.
259. Plaznik A., et al. The effect of 5,7-DHT-induced lesions of the median raphe nucleus and chronic desipramine administration upon motor behaviour of rats given intrahippocampal clonidine injection. J. Psychopharmacol. 1987, 1(4):258-263.
260. Popa D., et al. Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J. Neurosci. 2008, 28(14):3546-3554.
261. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266(5604):730-732.
262. Puelles L., et al. A developmental ontology for the mammalian brain based on the prosomeric model. Trends Neurosci. 2013, 36(10):570-578.
263. Rai D., et al. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013, 346:pf2059.
264. Rayen I., et al. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 2011, 6(9):e24003.
265. Rayen I., et al. Developmental fluoxetine exposure facilitates sexual behavior in female offspring. Psychopharmacology (Berl.) 2014, 231(1):123-133.
266. Rayen I., et al. Developmental exposure to SSRIs: in addition to maternal stress, has long-term sex-dependent effects on hippocampal plasticity. Psychopharmacology (Berl). 2015, 232(7):1231-1244.
267. Rebello T.J., et al. Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J. Neurosci. 2014, 34(37):12379-12393.
268. Ressler K.J., Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 2000, 12(Suppl. 1):2-19.
269. Rhoades R.W., et al. Effects of 5-HT on thalamocortical synaptic transmission in the developing rat. J. Neurophysiol. 1994, 72(5):2438-2450.
270. Riad M., Emerit M.B., Hamon M. Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture. Brain Res. Dev. Brain Res. 1994, 82(1-2):245-258.
271. Riccio O., et al. Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol. Psychiatry 2009, 14(3):280-290.
272. Riccio O., et al. Excess of serotonin affects neocortical pyramidal neuron migration. Transl Psychiatry 2011, 1:pe47.
273. Roberts C., et al. GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 2004, 46(7):935-941.
274. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 1997, 21(6):801-810.
275. Rodriguez-Porcel F., et al. Neonatal exposure of rats to antidepressants affects behavioral reactions to novelty and social interactions in a manner analogous to autistic spectrum disorders. Anat. Rec. 2011, 294(10):1726-1735.
276. Ruat M., et al. Molecular cloning: characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(18):8547-8551.
277. Sahay A., et al. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 2011, 472(7344):466-470.
278. Sales A.J., et al. Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br. J. Pharmacol. 2011, 164(6):1711-1721.
279. Sanchez M.M., Ladd C.O., Plotsky P.M. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev. Psychopathol. 2001, 13(3):419-449.
280. Sapolsky R.M., Krey L.C., McEwen B.S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc. Natl. Acad. Sci. U. S. A. 1984, 81(19):6174-6177.
281. Sarkar A., Chachra P., Vaidya V.A. Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation. Biol. Psychiatry 2014, 76(11):858-868.
282. Saudou F., Hen R. 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity. Adv. Pharmacol. 1994, 30:327-380.
283. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 1965, 122(5):509-522.
284. Schroeder F.A., et al. Antidepressant-like effects of the histone deacetylase inhibitor: sodium butyrate, in the mouse. Biol. Psychiatry 2007, 62(1):55-64.
285. Schwartz C.E., Snidman N., Kagan J. Adolescent social anxiety as an outcome of inhibited temperament in childhood. J. Am. Acad. Child Adolesc. Psychiatry 1999, 38(8):1008-1015.
286. Shapiro M.L., Eichenbaum H. Hippocampus as a memory map: synaptic plasticity and memory encoding by hippocampal neurons. Hippocampus 1999, 9(4):365-384.
287. Shephard R.A., Broadhurst P.L. Effects of diazepam and of serotonin agonists on hyponeophagia in rats. Neuropharmacology 1982, 21(4):337-340.
288. Sheridan M., et al. Early institutionalization: neurobiological consequences and genetic modifiers. Neuropsychol. Rev. 2010, 20(4):414-429.
289. Siegel A., Tassoni J.P. Differential efferent projections from the ventral and dorsal hippocampus of the cat. Brain Behav. Evol. 1971, 4(3):185-200.
290. Simpson K.L., et al. Perinatal antidepressant exposure alters cortical network function in rodents. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(45):18465-18470.
291. Soga T., et al. Early-life citalopram-induced impairments in sexual behavior and the role of androgen receptor. Neuroscience 2012, 225:172-184.
292. Soiza-Reilly M., Commons K.G. Glutamatergic drive of the dorsal raphe nucleus. J. Chem. Neuroanat. 2011, 41(4):247-255.
293. Spannuth B.M., et al. Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle. Neuroscience 2011, 179:104-119.
294. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 1992, 99(2):195-231.
295. Stahl S.M. Selectivity of SSRIs: individualising patient care through rational treatment choices. Int. J. Psychiatry Clin. Pract. 2004, 8(Suppl. 1):3-10.
296. Stead J.D., et al. Selective breeding for divergence in novelty-seeking traits: heritability and enrichment in spontaneous anxiety-related behaviors. Behav. Genet. 2006, 36(5):697-712.
297. Stedenfeld K.A., et al. Novelty-seeking behavior predicts vulnerability in a rodent model of depression. Physiol. Behav. 2011, 103(2):210-216.
298. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981, 6(4):557-618.
299. Stevenson E.L., Caldwell H.K. Lesions to the CA2 region of the hippocampus impair social memory in mice. Eur. J. Neurosci. 2014, 40(9):3294-3301.
300. Swanson L.W., Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J. Comp. Neurol. 1977, 172(1):49-84.
301. Tecott L.H., Maricq A.V., Julius D. Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(4):1430-1434.
302. Teitelman G., et al. Expression of amino acid decarboxylase in proliferating cells of the neural tube and notochord of developing rat embryo. J. Neurosci. 1983, 3(7):1379-1388.
303. Thomas H., et al. Lesion of the median raphe nucleus: a combined behavioral and microdialysis study in rats. Pharmacol. Biochem. Behav. 2000, 65(1):15-21.
304. Toffoli L.V., et al. Maternal exposure to fluoxetine during gestation and lactation affects the DNA methylation programming of rat's offspring: modulation by folic acid supplementation. Behav. Brain Res. 2014, 265:142-147.
305. Tokarski K., Kusek M., Hess G. 5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J. Physiol. Pharmacol. 2011, 62(5):535-540.
306. Tork I. Anatomy of the serotonergic system. Ann. N. Y. Acad. Sci. 1990, 600:9-34. discussion 34-5.
307. Trulson M.E., Frederickson C.J. A comparison of the electrophysiological and pharmacological properties of serotonin-containing neurons in the nucleus raphe dorsalis, raphe medianus and raphe pallidus recorded from mouse brain slices in vitro: role of autoreceptors. Brain Res. Bull. 1987, 18(2):179-190.
308. Tsankova N.M., et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 2006, 9(4):519-525.
309. Urbain N., Creamer K., Debonnel G. Electrophysiological diversity of the dorsal raphe cells across the sleep-wake cycle of the rat. J. Physiol. 2006, 573(Pt. 3):679-695.
310. Van Hartesveldt C., Moore B., Hartman B.K. Transient midline raphe glial structure in the developing rat. J. Comp. Neurol. 1986, 253(2):174-184.
311. Vataeva L.A., et al. Behavioral alteration in the adult rats prenatally exposed to para-chlorophenylalanine. Brain Res. 2007, 1169:9-16.
312. Vazquez-Palacios G., Bonilla-Jaime H., Velazquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(1):39-46.
313. Veenema A.H., Neumann I.D. Neurobiological mechanisms of aggression and stress coping: a comparative study in mouse and rat selection lines. Brain Behav. Evol. 2007, 70(4):274-285.
314. Velazquez-Moctezuma J., Diaz Ruiz O. Neonatal treatment with clomipramine increased immobility in the forced swim test: an attribute of animal models of depression. Pharmacol. Biochem. Behav. 1992, 42(4):737-739.
315. Vertes R.P., Kocsis B. Projections of the dorsal raphe nucleus to the brainstem: PHA-L analysis in the rat. J. Comp. Neurol. 1994, 340(1):11-26.
316. Verwer R.W., et al. Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex. Hippocampus 1997, 7(4):397-402.
317. Vialou V., et al. Epigenetic mechanisms of depression and antidepressant action. Annu. Rev. Pharmacol. Toxicol. 2013, 53:59-87.
318. Vijayakumar M., Meti B.L. Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression. Neurochem. Res. 1999, 24(3):345-349.
319. Vilaro M.T., et al. Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res. Mol. Brain Res. 1996, 43(1-2):356-360.
320. Vitalis T., et al. Embryonic depletion of serotonin affects cortical development. Eur. J. Neurosci. 2007, 26(2):331-344.
321. Vogel G., et al. A new animal model of endogenous depression: a summary of present findings. Neurosci. Biobehav. Rev. 1990, 14(1):85-91.
322. Weaver K.J., et al. Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects. Anat. Rec. 2010, 293(11):1920-1932.
323. Weikum W.M., et al. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(Suppl. 2):17221-17227.
324. Weikum W.M., et al. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age. Infant Behav. Dev. 2013, 36(4):485-493.
325. Weikum W.M., et al. Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age. Front. Cell. Neurosci. 2013, 7:180.
326. Wellman C.L., et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 2007, 27(3):684-691.
327. West P.J., et al. Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience 2009, 164(2):692-701.
328. West A.P. Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990, 14(6):863-877.
329. Whitaker-Azmitia P.M., Azmitia E.C. Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons. Brain Res. 1989, 497(1):80-85.
330. Whitaker-Azmitia P.M., Murphy R., Azmitia E.C. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor: protein S-100, and alters astroglial morphology. Brain Res. 1990, 528(1):155-158.
331. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 2001, 56(5):479-485.
332. White D.A., Kalinichev M., Holtzman S.G. Locomotor response to novelty as a predictor of reactivity to aversive stimuli in the rat. Brain Res. 2007, 1149:141-148.
333. Wilkinson L.S., Davies W., Isles A.R. Genomic imprinting effects on brain development and function. Nat. Rev. Neurosci. 2007, 8(11):832-843.
334. Witter M.P. A survey of the anatomy of the hippocampal formation, with emphasis on the septotemporal organization of its intrinsic and extrinsic connections. Excitatory Amino Acides and Epilepsy (Advances in Experimental and Medical Biology) 1986, 67-82. Plenum Press, New York. R. Schwarcz, Y. Ben-Ari (Eds.).
335. Wogelius P., et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006, 17(6):701-704.
336. Xu T., Pandey S.C. Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Res. Bull. 2000, 51(6):499-505.
337. Xu Y., Sari Y., Zhou F.C. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res. Dev. Brain Res. 2004, 150(2):151-161.
338. Yamawaki Y., et al. Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J. Biol. Psychiatry 2012, 13(6):458-467.
339. Yan W., Wilson C.C., Haring J.H. Effects of neonatal serotonin depletion on the development of rat dentate granule cells. Brain Res. Dev. Brain Res. 1997, 98(2):177-184.
340. Yang L.M., et al. Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus. Behav. Brain Res. 2008, 188(1):84-90.
341. Yannielli P.C., et al. Effects of neonatal clomipramine treatment on locomotor activity: anxiety-related behavior and serotonin turnover in Syrian hamsters. Neuropsychobiology 1999, 39(4):200-206.
342. Ye W., et al. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998, 93(5):755-766.
343. Yonkers K.A., et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet. Gynecol. 2009, 114(3):703-713.
344. Zardetto-Smith A.M., Johnson A.K. Chemical topography of efferent projections from the median preoptic nucleus to pontine monoaminergic cell groups in the rat. Neurosci. Lett. 1995, 199(3):215-219.
345. Zeskind P.S., Stephens L.E. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004, 113(2):368-375.
346. Zhang J., et al. Altered expression of tyrosine hydroxylase in the locus coeruleus noradrenergic system in citalopram neonatally exposed rats and monoamine oxidase a knock out mice. Anat. Rec. (Hoboken) 2011, 294(10):1685-1697.
347. Zhou F.C., Sari Y., Zhang J.K. Expression of serotonin transporter protein in developing rat brain. Brain Res. Dev. Brain Res. 2000, 119(1):33-45.
348. Zimmerberg B., Germeyan S.C. Effects of neonatal fluoxetine exposure on behavior across development in rats selectively bred for an infantile affective trait. Dev. Psychobiol. 2015, 57(2):141-152.
349. Zimmermann N., et al. Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem. J. 2012, 448(1):93-102.
350. Zohar I., Shoham S., Weinstock M. Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring. Eur. J. Neurosci. 2015.
351. Zou D., et al. DREADD in parvalbumin interneurons of the dentate gyrus modulates anxiety: social interaction and memory extinction. Curr. Mol. Med. 2016, 16(1):91-102.